Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 1;26(5):513-520.
doi: 10.1097/MOT.0000000000000909.

Gender disparities in transplantation

Affiliations
Review

Gender disparities in transplantation

Saulat S Sheikh et al. Curr Opin Organ Transplant. .

Abstract

Purpose of review: Transplantation is the life-saving therapy for patients suffering from end-organ failure, and as such, equitable access to transplantation (ATT) is of paramount importance. Unfortunately, gender/sex-based disparities exist, and despite the transplant community's awareness of this injustice, gender/sex-based disparities have persisted for more than two decades. Importantly, no legislation or allocation policy has addressed inequity in ATT that women disproportionately face. In fact, introduction of the model for end-stage liver disease-based liver allocation system in 2002 widened the gender disparity gap and it continues to be in effect today. Moreover, women suffering from kidney disease are consistently less likely to be referred for transplant evaluation and subsequently less likely to achieve a kidney transplant, yet they comprise the majority of living kidney donors.

Recent findings: Acknowledging gender/sex-based disparities in ATT is the first step toward interventions aimed at mitigating this long-standing injustice in healthcare.

Summary: This article provides a background of end-stage liver and kidney disease in women, summarizes the existing literature describing the issue of gender disparity in ATT, and identifies potential areas of intervention and future investigation.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Box 1
Box 1
no caption available

Similar articles

Cited by

References

    1. Hirode G, Saab S, Wong RJ. Trends in the burden of chronic liver disease among hospitalized US adults. JAMA Netw Open 2020; 3:e201997. - PMC - PubMed
    1. CDCMMWR. QuickStats: death rates for chronic liver disease and cirrhosis, by sex and age group — National Vital Statistics System, United States, 2000 and 2015. MMWR Morb Mortal Wkly Rep 2017; 66:1031. - PubMed
    1. Scaglione S, Kliethermes S, Cao G, et al. . The epidemiology of cirrhosis in the United States: a population-based study. J Clin Gastroenterol 2015; 49:690–696. - PubMed
    1. Davis GL, Alter MJ, El–Serag H, et al. . Aging of Hepatitis C Virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 2010; 138:513–521. e6. - PubMed
    1. Davis GL, Roberts WL. The healthcare burden imposed by liver disease in aging baby boomers. Curr Gastroenterol Rep 2010; 12:1–6. - PubMed